Clinical Trial Update: Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of ZVS101e in patients with Bietti crystalline dystrophy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bietti Crystalline Dystrophy

Drugs mentioned

• ZVS101e

Snippet

Sponsor: Chigenovo Co., Ltd | Conditions: Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy | Phase 3 | Status: RECRUITING